In the mid-1980s public health officials in North America, Europe, Japan, and Australia discovered that almost half of the hemophiliac population, as well as tens of thousands of blood transfusion recipients, had been infected with HIV-tainted blood. This book provides a comparative perspective on the political, legal, and social struggles that emerged in response to the HIV contamination of the industrialized worlds blood supply. It describes how eight nations responded to the first signs that AIDS might be transmitted through blood, and how they falteringly arrived at and finally implemented measures to secure the blood supply. The authors detail the remarkable saga of the mobilization of hemophiliacs who challenged the state, the medical establishment, and even their own caregivers as they sought recompense and justice. In the end, the blood establishments in almost every advanced industrial nation were shaken. In Canada, the Red Cross was forced to withdraw from blood collection and distribution. In Japan, pharmaceutical firms that manufactured clotting factor agreed to massive compensation -- $500,000 per hemophiliac infected. In France, blood officials went to prison. Even in Denmark, where the number of infected hemophiliacs was relatively small, the struggle and litigation surrounding blood has resulted in the most protracted legal and administrative conflict in modern Danish history. Blood Feuds brings together chapters on the experiences of the United States, Japan, France, Canada, Germany, Denmark, Italy, and Australia with four comparative essays that shed light on the cultural, institutional, and economic dimensions of the HIV/blood disaster.

In the mid-1980s public health officials in North America, Europe, Japan, and Australia discovered that almost half of the hemophiliac population, as well as tens of thousands of blood transfusion recipients, had been infected with HIV-tainted blood. This book provides a comparative perspective on the political, legal, and social struggles that emerged in response to the HIV contamination of the industrialized worlds blood supply. It describes how eight nations responded to the first signs that AIDS might be transmitted through blood, and how they falteringly arrived at and finally implemented measures to secure the blood supply. The authors detail the remarkable saga of the mobilization of hemophiliacs who challenged the state, the medical establishment, and even their own caregivers as they sought recompense and justice. In the end, the blood establishments in almost every advanced industrial nation were shaken. In Canada, the Red Cross was forced to withdraw from blood collection and distribution. In Japan, pharmaceutical firms that manufactured clotting factor agreed to massive compensation -- $500,000 per hemophiliac infected. In France, blood officials went to prison. Even in Denmark, where the number of infected hemophiliacs was relatively small, the struggle and litigation surrounding blood has resulted in the most protracted legal and administrative conflict in modern Danish history. Blood Feuds brings together chapters on the experiences of the United States, Japan, France, Canada, Germany, Denmark, Italy, and Australia with four comparative essays that shed light on the cultural, institutional, and economic dimensions of the HIV/blood disaster.

This volume is the second in a peer-reviewed series of Proceedings Volumes from the Calgary History of Medicine Days conferences, produced by Cambridge Scholars Publishing. The History of Medicine Days is a two day, national conference held annually at the University of Calgary, Canada, where undergraduate and early graduate students from across Canada, the US, the UK and Europe give paper and poster presentations on a wide variety of topics from the history of medicine and health care. The selected 2010 conference papers assembled in this volume particularly comprise the history of Applications of Science to Medicine, Nursing, Public Health, Illness and Disease, Stigma and Gender, Neurology and Psychiatry, and Eugenics. The 2010 keynote address was delivered by Distinguished Professor of the History of Nursing and Public Health, Dr Geertje Boschma from the University of British Columbia, Vancouver, and is reprinted in the current volume. This volume also includes the abstracts of all 2010 conference presentations and is well-illustrated with diagrams and images pertaining to the history of medicine.

While political and social historians have made great progress in trying to understand the making of modern Greece by studying * politics and power struggles, little attention has been given TO the co-evolution of the Greek state and the technologies that were developed during this period. This volume HELPS fills this gap, exploring the formation of the Greek state and the construction of 'modern' Greece through the lens of the history of technology and industry. The contributors look at the role of engineering institutions, the press and of infrastructure technological networks in promoting specific technocratic ideals and legitimizing social roles for the engineers of the period. The volume as a whole offers new insights into the way that engineering culture, institutional reforms and infrastructures contributed to the making of 'modern' Greece. Special Issue: History of Technology in Greece, from the Early 19th to 21st Century Edited by Stathis Arapostathis and Aristotelis Tympas

Society was not prepared in 1981 for the appearance of a new infectious disease, but we have since learned that emerging and reemerging diseases will continue to challenge humanity. AIDS at 30 is the first history of HIV/AIDS written for a general audience that emphasizes the medical response to the epidemic. Award-winning medical historian Victoria A. Harden approaches the AIDS virus from philosophical and intellectual perspectives in the history of medical science, discussing the process of scientific discovery, scientific evidence, and how laboratories found the cause of AIDS and developed therapeutic interventions. Similarly, her book places AIDS as the first infectious disease to be recognized simultaneously worldwide as a single phenomenon. After years of believing that vaccines and antibiotics would keep deadly epidemics away, researchers, doctors, patients, and the public were forced to abandon the arrogant assumption that they had conquered infectious diseases. By presenting an accessible discussion of the history of HIV/AIDS and analyzing how aspects of society advanced or hindered the response to the disease, AIDS at 30 illustrates for both medical professionals and general readers how medicine identifies and evaluates new infectious diseases quickly and what political and cultural factors limit the medical community’s response.

European public health was a playing field for deeply contradictory impulses throughout the twentieth century. In the 1920s, international agencies were established with great fanfare and postwar optimism to serve as the watchtower of health the world over. Within less than a decade, local-level institutions began to emerge as seats of innovation, initiative, and expertise. But there was continual counterpressure from nation-states that jealously guarded their policymaking prerogatives in the face of the push for cross-national standardization and the emergence of original initiatives from below. In contrast to histories of twentieth-century public health that focus exclusively on the local, national, or international levels, Shifting Boundaries explores the connections or "zones of contact" between the three levels. The interpretive essays, written by distinguished historians of public health and medicine, focus on four topics: the oscillation between governmental and nongovernmental agencies as sites of responsibility for addressing public health problems; the harmonization of nation-states' agendas with those of international agencies; the development by public health experts of knowledge that is both placeless and respectful of place; and the transportability of model solutions across borders. The volume breaks new ground in its treatment of public health as a political endeavor by highlighting strategies to prevent or alleviate disease as a matter not simply of medical techniques but political values and commitments. Contributors: Peter Baldwin, Iris Borowy, James A. Gillespie, Graham Mooney, Lion Murard, Dorothy Porter, Sabine Schleiermacher, Susan Gross Solomon, Paul Weindling, and Patrick Zylberman. Susan Gross Solomon is professor of political science at the University of Toronto. Lion Murard and Patrick Zylberman are both senior researchers at CERMES (Centre de Recherche Médecine, Sciences, Santé et Société), CNRS-EHESS-INSERM, Paris.

Disease and Democracy is the first comparative analysis of how Western democratic nations have coped with AIDS. Peter Baldwin's exploration of divergent approaches to the epidemic in the United States and several European nations is a springboard for a wide-ranging and sophisticated historical analysis of public health practices and policies. In addition to his comprehensive presentation of information on approaches to AIDS, Baldwin's authoritative book provides a new perspective on our most enduring political dilemma: how to reconcile individual liberty with the safety of the community. Baldwin finds that Western democratic nations have adopted much more varied approaches to AIDS than is commonly recognized. He situates the range of responses to AIDS within the span of past attempts to control contagious disease and discovers the crucial role that history has played in developing these various approaches. Baldwin finds that the various tactics adopted to fight AIDS have sprung largely from those adopted against the classic epidemic diseases of the nineteenth century—especially cholera—and that they reflect the long institutional memories embodied in public health institutions.

How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.